Publications by authors named "Darcy Thull"

Claim this Profile
D
Detection rates of multigene panel and exome testing in patients with previous negative BRCA1/2 results.
Jewel L Wasson, Trinity N Sprague, Darcy L Thull, Maureen May, Kathleen E Vitale

Fam Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Timely cancer genetic counseling and testing for young women with breast cancer: impact on surgical decision-making for contralateral risk-reducing mastectomy.
Shenin A Sanoba, Darcy L Thull, Priscilla F McAuliffe, Jennifer G Steiman, Ronald R Johnson

Breast Cancer Res Treat· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Release of reclassified VUS results of now deceased patients to family members: Practices and opinions.
Seth Lascurain, Darcy Thull, Andrea Durst, Todd Bear, Phuong L Mai

J Genet Couns· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers.
Christopher Hakkaart, John F Pearson, Louise Marquart, Joe Dennis, George A R Wiggins, Darcy L Thull

Commun Biol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timely cancer genetic counseling and testing for young women with breast cancer: impact on surgical decision-making for contralateral risk-reducing mastectomy.
Shenin A Sanoba, Darcy L Thull, Priscilla F McAuliffe, Jennifer G Steiman, Ronald R Johnson

Breast Cancer Res Treat· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk.
Eileen O Dareng, Jonathan P Tyrer, Daniel R Barnes, Michelle R Jones, Xin Yang, Darcy L Thull

Eur J Hum Genet· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polygenic risk modeling for prediction of epithelial ovarian cancer risk.
Eileen O Dareng, Jonathan P Tyrer, Daniel R Barnes, Michelle R Jones, Xin Yang, Darcy L Thull

Eur J Hum Genet· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores.
Daniel R Barnes, Valentina Silvestri, Goska Leslie, Lesley McGuffog, Joe Dennis, Darcy L Thull

J Natl Cancer Inst· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalising therapy for early-stage oestrogen receptor-positive breast cancer in older women.
Neil Carleton, Azadeh Nasrazadani, Kristine Gade, Sushil Beriwal, Parul N Barry, Darcy L Thull

Lancet Healthy Longev· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.
Inge M M Lakeman, Alexandra J van den Broek, Juliën A M Vos, Daniel R Barnes, Julian Adlard, Darcy L Thull

Genet Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.
Juliette Coignard, Michael Lush, Jonathan Beesley, Tracy A O'Mara, Joe Dennis, Darcy L Thull

Nat Commun· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.
Juliette Coignard, Michael Lush, Jonathan Beesley, Tracy A O'Mara, Joe Dennis, Darcy L Thull

Nat Commun· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.
Daniel R Barnes, Matti A Rookus, Lesley McGuffog, Goska Leslie, Thea M Mooij, Darcy L Thull

Genet Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.
Helian Feng, Alexander Gusev, Bogdan Pasaniuc, Lang Wu, Jirong Long, Darcy L Thull

Genet Epidemiol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.
Haoyu Zhang, Thomas U Ahearn, Julie Lecarpentier, Daniel Barnes, Jonathan Beesley, Darcy L Thull

Nat Genet· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knowledge and opinions regarding BRCA1 and BRCA2 genetic testing among primary care physicians.
Erin W Dekanek, Darcy L Thull, Mylynda Massart, Robin E Grubs, Aleksander Rajkovic

J Genet Couns· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.
Laura Fachal, Hugues Aschard, Jonathan Beesley, Daniel R Barnes, Jamie Allen, Darcy L Thull

Nat Genet· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The :p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.
Gisella Figlioli, Massimo Bogliolo, Irene Catucci, Laura Caleca, Sandra Viz Lasheras, Darcy L Thull

NPJ Breast Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer.
Manuel A Ferreira, Eric R Gamazon, Fares Al-Ejeh, Kristiina Aittomäki, Irene L Andrulis, Darcy L Thull

Nat Commun· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Tara M Friebel, Eitan Friedman, Ute Hamann, Dezheng Huo, Darcy L Thull

Hum Mutat· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.
Roger L Milne, Karoline B Kuchenbaecker, Kyriaki Michailidou, Jonathan Beesley, Siddhartha Kar, Darcy L Thull

Nat Genet· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
Catherine M Phelan, Karoline B Kuchenbaecker, Jonathan P Tyrer, Siddhartha P Kar, Kate Lawrenson, Darcy L Thull

Nat Genet· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.
Valentina Silvestri, Daniel Barrowdale, Anna Marie Mulligan, Susan L Neuhausen, Stephen Fox, Darcy L Thull

Breast Cancer Res· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological comparison of colorectal and endometrial carcinomas in patients with Lynch-like syndrome versus patients with Lynch syndrome.
Jenny Mas-Moya, Beth Dudley, Randall E Brand, Darcy Thull, Nathan Bahary

Hum Pathol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline MLH1 Mutations Are Frequently Identified in Lynch Syndrome Patients With Colorectal and Endometrial Carcinoma Demonstrating Isolated Loss of PMS2 Immunohistochemical Expression.
Beth Dudley, Randall E Brand, Darcy Thull, Nathan Bahary, Marina N Nikiforova

Am J Surg Pathol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis